MedPath

To find out the benefit of alternate day versus daily oral iron therapy in iron deficient childre

Not Applicable
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Registration Number
CTRI/2023/08/056597
Lead Sponsor
DR PRANATI GROVER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients between 6 months to 10 years of age diagnosed with iron deficiency anemia

Exclusion Criteria

Patients who have received blood transfusion in past 3 months, oral or injectable iron supplements, patients with hemoglobinopathies, premature infants born before 32 weeks of gestation, patient with active infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the efficacy of alternate versus twice daily oral iron therapy in children with iron deficiency anemiaTimepoint: Over a span of one year
Secondary Outcome Measures
NameTimeMethod
1. Effect of alternate versus twice daily oral iron therapy on serum hepcidin levels <br/ ><br>2. To compare the GI side effects in both the groups that may affect the compliance.Timepoint: Over a span of 1 year.
© Copyright 2025. All Rights Reserved by MedPath